breaking

Montana Legislature Debates Future of Medicaid ExpansionThe fate of Montana's Medicaid expansion program hangs in the balance as the 2025 state legislature gears up for what is expected to be a contentious and pivotal...

**Scribe Therapeutics Layoffs: A CRISPR Company in Turmoil**Scribe Therapeutics, a pioneering company in the realm of CRISPR gene editing, has recently confirmed the unfortunate news of laying off almost 20% of its workforce. This...

California Governor Gavin Newsom has been on a mission to revolutionize healthcare in the Golden State since taking office six years ago. His ambitious plans have included expanding access to care, controlling costs, and...

Medicaid in a Second Trump Presidency: Changes and ImpactsMedicaid patients across the nation are on edge as the new administration prepares to take office. While President Trump has assured the public of his commitment...

California's Health Care Future at Risk Amid Political TurmoilIn a state as vast as California, health care remains a pressing issue, with Governor Gavin Newsom at the helm of ambitious reform efforts. However, with...

Exploring the Potential Benefits of Epilepsy Medication Beyond Seizure ReductionAs we dive into the first workweek of 2025, the biotech industry is already buzzing with exciting developments. From groundbreaking weight loss treatments to innovative...

Health News Recap: A Dark Anniversary and Recent UpdatesAs we kick off the new year, let's take a moment to delve into the latest health news that has been making waves. From the shaping...

The United States has faced its first fatal case of H5N1 bird flu, which has sparked concerns about the potential impact of the virus. The individual, who hailed from Louisiana and was over 65...

Exploring the Impact of Racism and Violence on HealthIn a riveting conversation between KFF Health News Midwest correspondent Cara Anthony and Emily Kwong, host of NPR's podcast "Shortwave," the deep-rooted effects of racism and...

FDA Issues Draft Guidance on AI Use in Drug DevelopmentIn a groundbreaking move, the Food and Drug Administration (FDA) has released its first draft guidance on the application of artificial intelligence (AI) in the...